ReqMed Company,Ltd.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
Expected Date |
| 529A |
Pharmaceuticals |
Growth |
Nomura Securities Co., Ltd |
2026/02/26 |
2026/04/02 |
| 【Description】 |
| |
IPO Information |
| Listed Shares(total) |
1,339,300 |
Trading Unit |
100 |
| New Shares |
1,339,300 |
Existing Shares |
0 |
| Shares Outstanding |
Pre IPO |
6,828,000.00 |
| PostIPO |
8,167,300.00 |
| Paid Up Capital |
PreIPO |
Y100,000,000 |
| PostIPO |
|
| Expected Pricing Date |
2026/03/13 |
| Book Building Start |
2026/03/17 |
Book Building End |
2026/03/23 |
| Fix Date |
2026/03/24 |
| Offering Starts |
2026/03/25 |
Offering Ends |
2026/03/30 |
| Expect Pricing |
|
Notional PER
(based on previous period) |
|
| Offering Price |
|
Offering Price PER
(based on previous period) |
|
Offering Price PBR
(based on previous period) |
|
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2023/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
49,571 |
-329,555 |
-329,845 |
40,739 |
| 2024/03 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
318,881 |
-211,268 |
-227,671 |
1,022,805 |
| 2025/03 |
Consolidated |
- |
- |
- |
- |
| Consolidated |
479,403 |
-115,979 |
-120,660 |
902,144 |
Interim Results
2025/09 |
Non-consolidated |
- |
- |
- |
- |
| Consolidated |
230,536 |
-466,738 |
-467,213 |
1,763,101 |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2023/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
-86.09 |
10.63 |
|
| 2024/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
-51.35 |
191.09 |
|
| 2025/03 |
Non-consolidated |
0.00 |
- |
- |
|
| Consolidated |
-22.54 |
168.55 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Interim Results
2025/09 |
Non-consolidated |
|
- |
- |
|
| Consolidated |
-74.90 |
- |
|
Comment |
| ■Over allotment (200,800) |
Consolidated Subsidiaries |
| Name |
Address |
Underwriters |
| Allocation |
Underwriter |
Tel |
| 0% |
Nomura Securities Co., Ltd |
03-3211-1811 |
| 0% |
OKASAN SECURITIES GROUP INC |
03-3272-2211 |
| 0% |
Marusan Securities Co., Ltd |
03-3272-5211 |
| 0% |
SBI SECURITIES Co.,Ltd. |
03-5562-7210 |
| 0% |
Matsui Securities Co., Ltd |
03-5216-0606 |
Data |
| Date of incorporation |
1998/05/12 |
| Company address |
Tokyo 194-0022 |
| Telephone |
042-732-2207 |
| President |
|
| Homepage |
https://www.reqmed.co.jp/ |
| Auditor |
RSM Seiwa |
|
|
Major Shareholders |
| Shareholder Name |
Ratio |
| |
11.87% |
| |
10.02% |
| |
8.38% |
| |
8.38% |
| |
5.57% |
| |
4.76% |
| |
3.89% |
| |
3.58% |
| |
3.55% |
| |
3.35% |
| Number of Employees |
22 as of 2026/01/31 |
| Birth Date of Representative |
1953/06/24 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
